Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia — HAB

Hypertonia Clinical Trial

Official title:
Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia

Status Terminated

Clinical Trial Summary

The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .

In addition, data are collected on the immune system as well as for food and sleep quality.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01902602
Study type	Observational
Source	Herrmann Apparatebau GmbH
Contact
Status	Terminated
Phase
Start date	August 2013
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01681888` - Surface EMG Biofeedback for Children With Cerebral Palsy	N/A
Completed	`NCT00473161` - Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy	Phase 1/Phase 2
Terminated	`NCT00221689` - Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients	Phase 2
Completed	`NCT00472914` - Use of EMG to Assess Clinical Hypertonia	Phase 1/Phase 2
Completed	`NCT00394641` - Impact of Listening to Low Tones on Motor Function in Children With CP	N/A